EuroSIDA Publications 2023
  1. Hepatitis delta infection among persons living with HIV in Europe. Béguelin C, Atkinson A, Boyd A, Falconer K, Kirkby N, Suter-Riniker F, Günthard HF, Rockstroh JK, Mocroft A, Rauch A, Peters L, Wandeler G; for EuroSIDA and SHCS.
    Liver Int. 2023;43(4):819-828. Abstract
  2. External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection. Surial B, Mena AR, Roumet M, Limacher A, Smit C, Leleux O, Mocroft A, van der Valk M, Bonnet F, Peters L, Rockstroh JK, Günthard HF, Berzigotti A, Rauch A, Wandeler G; Swiss HIV Cohort Study, ATHENA Observational Cohort Study, EuroSIDA, ANRS CO3 Aquitaine Cohort.
    J Hepatol. 2023:S0168-8278(23)00011-9. Epub ahead of print. Abstract
  3. Plasma HIV-1 RNA and CD4+ T-cell counts are determinants of virological non-suppression outcomes with initial integrase inhibitor-based regimens: A prospective RESPOND cohort study. Álvarez H, Mocroft A, Ryom L, Neesgaard B, Edwards S, Svedhem VN, Günthard HF, Zangerle R, Smith C, Castagna A, D Arminio Monforte A, Wit F, Stecher M, Lehman C, Mussini C, Fontas E, González E, Wasmuth JC, Sönnerborg A, De Wit S, Chkhartishvili N, Stephan C, Petoumenos K, Jaschinski N, Vannappagari V, Gallant J, Young L, Volny Anne A, Greenberg L, Martín-Iguacel R, Poveda E, Llibre JM; RESPOND (International Cohort Consortium of Infectious Diseases) Study Group.
    Clin Infect Dis. 2023:ciad219. Epub ahead of print. Abstract
  4. Trends in Cancer Incidence in Different Antiretroviral Treatment-Eras amongst People with HIV Greenberg L, Ryom L, Bakowska E, Wit F, Bucher HC, Braun DL, Phillips A, Sabin C, d'Arminio Monforte A, Zangerle R, Smith C, De Wit S, Bonnet F, Pradier C, Mussini C, Muccini C, Vehreschild JJ, Hoy J, Svedhem V, Miró JM, Wasmuth JC, Reiss P, Llibre JM, Chkhartishvili N, Stephan C, Hatleberg CI, Neesgaard B, Peters L, Jaschinski N, Dedes N, Kuzovatova E, Van Der Valk M, Menozzi M, Lehmann C, Petoumenos K, Garges H, Rooney J, Young L, Lundgren JD, Bansi-Matharu L, Mocroft A, on behalf of the RESPOND and D:A:D Study Groups.
    Cancers. 2023. Jul 15;15(14):3640 Epub ahead of print. Abstract

Total publications April 2023: 335




  1. Heavy ARV exposure and exhausted/limited ARV options: predictors and clinical outcomes. Amanda Mocroft, A Pelchen-Matthews, J Hoy, JM Llibre, B Neesgaard, N Jaschinski, P Domingo, L Dahlerup Rasmussen, HF Günthard, B Surial, A Öllinger, M Knappik, S De Wit, F Wit, C Mussini, J Vehreschild, A D’Arminio Monforte, A Sonnerborg, A Castagna, A Volny Anne, V Vannappagari, C Cohen, W Greaves, JC Wasmuth, V Spagnuolo, L Ryom for the RESPOND cohort collaboration. AIDS, 2023